Atrial fibrillation: diagnosis and management

Excerpt

This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding.

The recommendations in this guideline were developed before the COVID-19 pandemic.

See the MHRA advice on warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic, which includes reports of supratherapeutic anticoagulation with warfarin.

Who is it for?:

1. Healthcare professionals

2. Commissioners and providers

3. People with atrial fibrillation, their families and carers